ATyr Pharma (LIFE) Stock Highlights

1.87 | -0.53%

2024-11-21 05:42:36

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. Its lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need.

Statistics

Range Today

1.85 1.93

Volume Today 186.86K

Range 1 Year

1.08 2.5

Volume 1 Year 100.75M

Range 3 Year

1.08 13.1

Volume 3 Year 554.16M

Range 10 Year

1.08 396.06

Volume 10 Year 779.64M

Highlights

Market Capitalization 131.12M (small)

Floating Shares 67.12M

Current Price 1.87

Price To Earnings -2.11

Price To Revenue 93.61

Price To Book 1.54

Earnings Per Share -0.88

Payout Ratio 0%

Performance

Latest -0.53%

1 Month +23.84%

3 Months +13.33%

6 Months +8.72%

1 Year -6.97%

3 Years -60.47%

5 Years -40.63%

10 Years -98.99%

Benchmarks

Market Capitalization

254 / 368

Gross Profits

182 / 278

Total Revenue

182 / 300

Total Rank

194 / 368

Free Cashflow

154 / 352

Performance 5 years

167 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.